| http://www.w3.org/ns/prov#value | - Founded in 2001, Selexis offers technologies and services designed to significantly reduce the time, effort, and costs associated with developing high-performance mammalian cell lines for therapeutic protein production, such as monoclonal antibodies, growth factors, and enzymes.
|
